![Sotirios Stergiopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sotirios Stergiopoulos
Président chez
ROQT THER
Profil
Dr. Sotirios G.
Stergiopoulos, MD, is a President & Chief Executive Officer at A2a Pharmaceuticals, Inc. and an Executive Chairman at Coiled Therapeutics Plc.
He is on the Board of Directors at Ricovr Healthcare, Inc. Dr. Stergiopoulos was previously employed as an Independent Director by Biomea Fusion, Inc., a Chief Medical Officer & Senior Vice President by Ipsen Pharmaceuticals, Inc., a Chief Medical Officer & Senior Vice President by Ipsen SA, a Vice President & Head-Global Medical Affairs by Baxalta, Inc., a Vice President & Head-Global Medical Affairs by Shire Plc, an Executive Director-US Medical Affairs Oncology by Celgene Corp., a Senior Director-Global Brand Medical by Novartis AG, and a Deputy Director-Global Medical Affairs Oncology by Bayer Healthcare LLC.
He received his undergraduate degree from Stony Brook University, a graduate degree from The Johns Hopkins University and a doctorate degree from Poznan University of Medical Science.
Postes actifs de Sotirios Stergiopoulos
| Sociétés | Poste | Début |
|---|---|---|
| ROQT THER | Président | - |
A2a Pharmaceuticals, Inc.
 A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs | Directeur Général | 02/07/2019 |
Ricovr Healthcare, Inc.
 Ricovr Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and sells oral diagnostic medical devices | Directeur/Membre du Conseil | - |
Anciens postes connus de Sotirios Stergiopoulos
| Sociétés | Poste | Fin |
|---|---|---|
| IPSEN | Directeur Technique/Scientifique/R&D | 01/06/2019 |
Ipsen Pharmaceuticals, Inc.
 Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/06/2019 |
| BAXALTA INC | Corporate Officer/Principal | 01/10/2016 |
| SHIRE | Corporate Officer/Principal | 01/10/2016 |
| CELGENE | Corporate Officer/Principal | 01/01/2016 |
Formation de Sotirios Stergiopoulos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Pharmaceuticals, Inc.
Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Poznan University of Medical Science
 Poznan University of Medical Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
A2a Pharmaceuticals, Inc.
A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs | Technology Services |
Ricovr Healthcare, Inc.
Ricovr Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and sells oral diagnostic medical devices | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Biomea Fusion, Inc.
 Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
